文献速递肿瘤 PET/CT放射性药物与辐射防护

新型68Ga-FAPI PET/CT可实现无COVID-19疫苗相关陷阱的肿瘤分期

Novel 68Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine-Related Pitfalls.
PubMed 文献 · J Nucl Med · 2022-11-17

在COVID-19疫苗接种背景下,疫苗相关示踪剂在区域淋巴结的摄取已成为18F-FDG PET/CT肿瘤分期的已知问题。本研究在一项大型前瞻性影像登记研究的11例患者中,头对头同日比较了接种后18F-FDG与68Ga-FAPI-46 PET/CT表现。结果显示,18F-FDG PET/CT在11例(100%)患者中均可见注射部位邻近淋巴结明显摄取,而68Ga-FAPI PET/CT为0例(0%);68Ga-FAPI PET/CT检测到94%的肿瘤病灶,18F-FDG检测到73%。

要点

  • 接种后18F-FDG PET/CT在11/11(100%)患者中见注射部位邻近淋巴结摄取,68Ga-FAPI PET/CT为0/11(0%)。
  • 68Ga-FAPI PET/CT检测到94%的肿瘤病灶,18F-FDG PET/CT检测到73%。
  • 68Ga-FAPI显示出避免18F-FDG PET/CT接种后陷阱及更优肿瘤定位的潜力。

核心结论

  • 在这项病例系列研究中,68Ga-FAPI显示出避免18F-FDG PET/CT接种后陷阱的潜力,并呈现更优的肿瘤定位。

研究设计与样本

  • 研究纳入来自大型前瞻性影像登记研究的11例患者,均在接种后6周内PET/CT或PET/MRI显示区域淋巴结示踪剂摄取,并接受接种后头对头同日18F-FDG与68Ga-FAPI-46 PET/CT检查。

主要发现

  • 18F-FDG PET/CT在11/11(100%)患者中见注射部位邻近淋巴结明显视觉摄取,68Ga-FAPI PET/CT为0/11(0%)。
  • 68Ga-FAPI PET/CT检测到94%的肿瘤病灶,18F-FDG PET/CT检测到73%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the setting of ongoing coronavirus disease 2019 vaccination, vaccine-related tracer uptake in locoregional lymph nodes has become a well-known issue in tumor staging by 18F-FDG PET/CT. 68Ga-fibroblast-activation protein inhibitor (FAPI) PET/CT is a new oncologic imaging tool that may overcome this limitation. Methods: We assessed postvaccine head-to-head and same-day 18F-FDG and 68Ga-FAPI-46 PET/CT findings in a series of 11 patients from a large, prospective imaging registry. All patients with documented tracer uptake in locoregional lymph nodes on PET/CT or PET/MRI, after vaccination within 6 wk, were eligible for investigation. Result: Significant visual lymph node uptake adjacent to the injection site was noted in 11 of 11 (100%) patients with 18F-FDG PET/CT, versus 0 of 11 (0%) with 68Ga-FAPI PET/CT. 18F-FDG detected 73% and 68Ga-FAPI PET/CT 94% of all tumor lesions. Conclusion: In this case-series study, 68Ga-FAPI showed its potential to avoid 18F-FDG PET/CT postvaccination pitfalls and presented superior tumor localization.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Demmert TT, Maric I, Pomykala KL, et al. Novel 68Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine-Related Pitfalls. J Nucl Med. 2022. PMID: 36396454. doi:10.2967/jnumed.122.264872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。